Bottom line
IBND vs XLV: the short answer
IBND (State Street(R) SPDR(R) Bloomberg International Corporate Bond ETF) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both etfs.
But IBND is far broader, holding 949 positions to 65 for XLV, so beyond the top names it adds exposure XLV doesn't have.
XLV is cheaper at 0.08% vs 0.5% — a difference of $42 a year per $10,000 invested.
Over five years, XLV returned +8.1% a year vs −1.7% for IBND.
Updated Nov 19, 2026
IBND vs XLV side by side
| IBND | XLV | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | SPDR (State Street) | SPDR (State Street) |
| Category | Global Bond | Health Care Sector |
| Expense ratio | 0.5% | 0.08% |
| Annual cost per $10k | $50 | $8 |
| 10-yr cost on $10k (prospectus) | $628 | $103 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0.02% |
| 1-yr return | +15.8% | +14.5% |
| 5-yr return (annualized) | −1.7% | +8.1% |
| 10-yr return (annualized) | +1.5% | +9.8% |
| Best quarter | +10.6% | +14.5% |
| Worst quarter | −12.8% | −12.7% |
| Net assets (fund) | $461.6M | $40.6B |
| Number of holdings | 949 | 65 |
| Portfolio turnover | 29% | 2% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | IBND | XLV | Difference |
|---|---|---|---|
| 2025 | +15.8% | +14.5% | +1.3% |
| 2024 | −2.5% | +2.5% | −5.0% |
| 2023 | +11.1% | +2.0% | +9.1% |
| 2022 | −19.9% | −2.1% | −17.8% |
| 2021 | −8.4% | +25.9% | −34.3% |
| 2020 | +11.7% | +13.3% | −1.6% |
| 2019 | +4.6% | +20.7% | −16.1% |
| 2018 | −6.4% | +6.3% | −12.7% |
| 2017 | +14.8% | +21.7% | −6.9% |
| 2016 | −0.0% | −2.8% | +2.8% |
Source: Fund prospectus bar charts
Holdings overlap
IBND and XLV share none of their top holdings.
IBND top 10
- State Street Global Advisors — 0.60%
- Anheuser-busch Inbev Sa/ — 0.32%
- JPMorgan Chase & Co. — 0.28%
- Amazon.com Inc — 0.27%
- Amazon.com Inc — 0.27%
- Banco Santander Sa — 0.26%
- Ubs Group Ag — 0.25%
- Banco Santander Sa — 0.25%
- Ntt Finance Corp — 0.25%
- Morgan Stanley — 0.25%
XLV top 10
- Eli Lilly & Co — 16.51%
- Johnson & Johnson — 10.64%
- AbbVie Inc — 7.74%
- UnitedHealth Group Inc — 6.57%
- Merck & Co Inc — 5.52%
- Amgen Inc — 3.40%
- Thermo Fisher Scientific Inc — 3.24%
- Abbott Laboratories — 2.75%
- Gilead Sciences Inc — 2.73%
- Intuitive Surgical Inc — 2.45%
FAQ
What is the difference between IBND and XLV?
Which is cheaper, IBND or XLV?
Should I own both IBND and XLV?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.